Jeong-Ah Kim Selected Research

cytomegalovirus matrix protein 65kDa

1/2022

Antibody-mediated delivery of a viral MHC-I epitope into the cytosol of target tumor cells repurposes virus-specific CD8+ T cells for cancer immunotherapy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jeong-Ah Kim Research Topics

Disease

13	Neoplasms (Cancer) 01/2022 - 06/2008
6	Breast Neoplasms (Breast Cancer) 09/2021 - 12/2011
3	Hemorrhagic Fever with Renal Syndrome (HFRS) 01/2021 - 04/2016
3	Papillary Thyroid Cancer 03/2018 - 06/2014
2	Infections 01/2022 - 04/2021
2	Lymphatic Metastasis 03/2018 - 02/2016
2	Inflammation (Inflammations) 07/2014 - 06/2009
2	Stroke (Strokes) 08/2013 - 02/2013
2	Triple Negative Breast Neoplasms 08/2012 - 12/2011
2	Colonic Neoplasms (Colon Cancer) 09/2011 - 11/2009
2	Leukemia 09/2010 - 01/2010
1	Reinfection 01/2022
1	Virus Diseases (Viral Diseases) 01/2022
1	Low Tension Glaucoma 01/2022
1	Dementia (Dementias) 01/2022
1	Microphthalmos 12/2021
1	Diabetic Retinopathy (Retinopathy, Diabetic) 12/2021
1	Pathologic Complete Response 01/2020
1	Ischemic Optic Neuropathy (Anterior Ischemic Optic Neuropathy) 01/2020
1	Carcinoma (Carcinomatosis) 07/2019
1	Asthma (Bronchial Asthma) 01/2019
1	Atopic Dermatitis (Atopic Eczema) 01/2019
1	Margins of Excision 09/2018
1	Glaucoma 01/2018
1	Optic Nerve Diseases (Optic Neuropathy) 01/2018
1	Thyroid Nodule (Nodule, Thyroid) 06/2017
1	Carotid Artery Diseases 02/2017
1	Cardiovascular Diseases (Cardiovascular Disease) 02/2017
1	Atherosclerosis 02/2017
1	Open-Angle Glaucoma (Glaucoma, Open Angle) 01/2017
1	Papillary Thyroid Microcarcinoma 02/2016
1	Corneal Opacity 07/2014
1	Edema (Dropsy) 07/2014
1	Aphasia (Dysphasia) 08/2013
1	Hemorrhagic Stroke 02/2013

Drug/Important Bio-Agent (IBA)

3	Retinaldehyde (Retinal)IBA 01/2020 - 01/2017
3	Estrogen ReceptorsIBA 07/2014 - 12/2011
3	Progesterone Receptors (Progesterone Receptor)IBA 07/2014 - 08/2012
2	RNA (Ribonucleic Acid)IBA 01/2021 - 04/2016
2	CytokinesIBA 01/2018 - 11/2007
2	Proteins (Proteins, Gene)FDA Link 07/2014 - 12/2011
2	Reactive Oxygen Species (Oxygen Radicals)IBA 09/2011 - 12/2008
2	EnzymesIBA 11/2009 - 12/2008
1	EpitopesIBA 01/2022
1	Viral AntigensIBA 01/2022
1	Ophthalmic Solutions (Eye Drops)IBA 01/2022
1	Donepezil (Aricept)FDA LinkGeneric 01/2022
1	Viral RNAIBA 01/2022
1	cytomegalovirus matrix protein 65kDaIBA 01/2022
1	Rivastigmine (Exelon)FDA LinkGeneric 01/2022
1	Cancer VaccinesIBA 01/2022
1	T-Lymphocyte Epitopes (Epitopes, T Lymphocyte)IBA 01/2022
1	Peptides (Polypeptides)IBA 01/2022
1	Memantine (Namenda)FDA Link 01/2022
1	Histocompatibility Antigens Class IIBA 01/2022
1	Galantamine (Galanthamine)FDA LinkGeneric 01/2022
1	Antiviral Agents (Antivirals)IBA 04/2021
1	AntibodiesIBA 01/2020
1	5- (2,4- dihydroxy- 5- isopropylphenyl)- 4- (4- morpholin- 4- ylmethylphenyl)isoxazole- 3- carboxylic acid ethylamideIBA 01/2020
1	GlycogenIBA 07/2019
1	Interleukin-13 Receptors (Interleukin 13 Receptor)IBA 01/2019
1	Interleukin-4 Receptors (Interleukin 4 Receptor)IBA 01/2019
1	InterferonsIBA 01/2018
1	Interleukin-12 (IL 12)IBA 01/2018
1	Biological ProductsIBA 06/2017
1	Vitamin D FDA LinkGeneric 02/2017
1	Immunoglobulins (Immunoglobulin)IBA 04/2016
1	Galectin 3 (LGALS3)IBA 02/2016
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 07/2014
1	human ERBB2 proteinIBA 07/2014
1	Thyroglobulin FDA Link 06/2014
1	Therapeutic UsesIBA 08/2013
1	Phenobarbital (Luminal)FDA Link 02/2013
1	ErbB Receptors (EGF Receptor)IBA 02/2013
1	NFI Transcription FactorsIBA 12/2011
1	Messenger RNA (mRNA)IBA 12/2011
1	AntioxidantsIBA 09/2011
1	chrysoeriolIBA 09/2010
1	bruceantinIBA 09/2010
1	SteroidsIBA 03/2010
1	TriterpenesIBA 03/2010
1	DammaranesIBA 01/2010
1	SaponinsIBA 01/2010
1	NF-kappa B (NF-kB)IBA 11/2009
1	Chloroform (Trichloromethane)IBA 11/2009
1	11-hydroxy-3-O-methyl-1-isomangostinIBA 11/2009
1	xanthoneIBA 11/2009
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 06/2009

Therapy/Procedure

3	Neoadjuvant Therapy 09/2021 - 01/2020
2	Immunotherapy 01/2022 - 01/2020
1	Vitrectomy 12/2021
1	Segmental Mastectomy (Lumpectomy) 09/2018
1	Lymph Node Excision (Lymph Node Dissection) 03/2018
1	Injections 01/2018
1	Language Therapy (Language Training) 08/2013
1	Music Therapy 08/2013
1	Therapeutics 08/2013
1	Activities of Daily Living (ADL) 02/2013
1	Transcranial Magnetic Stimulation 02/2013
1	Drug Therapy (Chemotherapy) 09/2010